Journal article icon

Journal article

Incidence of Respiratory Syncytial Virus Infection in Older Adults: Limitations of Current Data

Abstract:
This study explores the epidemiological trends of pathogens and respiratory co-infections in Messina, focusing on various age groups from pediatric to elderly patients. Acute respiratory tract infections (ARI) significantly impact global morbidity and mortality rates, particularly in children under five. The Global Burden of Disease (GBD) data indicates 17.2 billion cases of upper respiratory tract infections globally in 2019. The study analyzes the prevalence of respiratory pathogens, including SARS-CoV-2, influenza, and respiratory syncytial virus (RSV). Post-summer 2022, there was a significant rise in respiratory diseases, with peaks in different viruses, especially among vulnerable age groups. A retrospective study on 1,286 patients at the University Hospital "G. Martino" in Messina employed the FilmArray (Biofire RP2.1 by Biomerieux) for pathogen detection. The results identified SARS-CoV-2, Human Rhinovirus, and RSV as the most frequently isolated pathogens. Co-infections were prevalent, particularly in children aged 0-4 years, with seasonal infection peaks in the winter months. The study concludes that improving diagnostic tools and surveillance systems enhances patient management and reduces antibiotic use and ICU admissions. The findings highlight the necessity for ongoing surveillance and targeted preventive measures, particularly for young children and the elderly. The introduction of new vaccines and monoclonal antibodies offers promising future prevention strategies. This research underscores the critical need for robust surveillance and prevention programs to mitigate the impact of respiratory infections, thereby improving public health outcomes
Publication status:
Published
Peer review status:
Peer reviewed

Actions

Access Document

Files:
Publisher copy:
10.1007/s40121-023-00802-4

Authors

More by this author
Role:
Author
ORCID:
0000-0001-6209-4370
More by this author
Role:
Author
ORCID:
0000-0002-1287-5416
More by this author
Role:
Author
ORCID:
0000-0003-2392-8111
More by this author
Role:
Author
ORCID:
0000-0003-0589-7980


Publisher:
Springer
Journal:
Infectious Diseases and Therapy More from this journal
Volume:
12
Issue:
6
Pages:
1487-1504
Publication date:
2023-05-23
DOI:
EISSN:
2193-6382
ISSN:
2193-8229


Language:
English
Keywords:
Pubs id:
1469412
Local pid:
pubs:1469412
Source identifiers:
W4380422476
Deposit date:
2026-05-08
ARK identifier:
This ORA record was generated from metadata provided by an external service. It has not been edited by the ORA Team.

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP